Galanthamine

In 1951, the Russian pharmacologist Mikhail Mashkovsky discovered that local villagers from the Urals used the wild snowdrop (Galanthus spp., most notably Galanthus woronowii Losinsk.) to stave off paralysis in children suffering from poliomyelitis. The ethnobotanical use of the snowdrop in the Urals led to the isolation of galanthamine for the first time in 1952, an alkaloid with AChE-inhibiting propertiesAlkaloid from caucasian snow-drop Galenthus woronowii, the common snowdrop Galanthus nivalis Ungernia genus, Amaryllidaceae, from Narcissus spp. Selectivity for AChE. The CAS number of Galanthamine Hydrobromide is 1953-04-4. || Nivalin Reminyl trademark approved for treatment of Alzheimer disease in Austria. || Galantamine is a specific competitive and reversible aceylcholinesterase inhibitor. It is also an allosteric modulator at nicotinic cholinergic receptor sites potentiating cholinergic nicotinic neurotransmission at the ganglionic and the neuromuscular junctions.

General

Type : Derivative of Galanthamine, Natural, Alkaloid, Drug, Benzazepin, Azepane, Multitarget, Nicotinic agonist

Chemical_Nomenclature : 1,2,3,4,6,7,7a,11c-octahydro-9-methoxy-2methylbenzofuro[4,3,2-efg][2]benzazocin-6-ol

Canonical SMILES : CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O

InChI : InChI=1S\/C17H21NO3\/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17\/h3-6,12,14,19H,7-10H2,1-2H3\/t12-,14-,17-\/m0\/s1

InChIKey : ASUTZQLVASHGKV-JDFRZJQESA-N

Other name(s) : Galantamine  ||  Lycoremine  ||  Jilkon  ||  Nivalin  ||  Reminyl  ||  Razadyne


MW : 287.35

Formula : C17H21NO3

CAS_number : 357-70-0

PubChem : 9651

UniChem : ASUTZQLVASHGKV-JDFRZJQESA-N

IUPHAR : 6693

Wikipedia : Galanthamine

Target

Families : Galanthamine ligand of proteins in family
ACHE

Structure :
1DX6 1QTI 1W6R 1W76 4EY6

Protein :
torca-ACHE human-ACHE

References (89)

Title : Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment - Lim_2024_Cochrane.Database.Syst.Rev_11_Cd001747
Author(s) : Lim AWY , Schneider L , Loy C
Ref : Cochrane Database Syst Rev , 11 :Cd001747 , 2024
Abstract :
PubMedSearch : Lim_2024_Cochrane.Database.Syst.Rev_11_Cd001747
PubMedID: 39498781

Title : The Effect of Galantamine on Lipopolysaccharide-induced Acute Lung Injury During Neutropenia Recovery in Mice - Kwon_2024_In.Vivo_38_606
Author(s) : Kwon OB , Seo W , Kim KY , Joo H , Yeo CD , Kim JW
Ref : In Vivo , 38 :606 , 2024
Abstract :
PubMedSearch : Kwon_2024_In.Vivo_38_606
PubMedID: 38418160

Title : Cholinergic Crisis with Normal Serum Cholinesterase Levels due to Excessive Galantamine Ingestion: A Case Report - Suzuki_2024_Jma.j_7_292
Author(s) : Suzuki A , Mayahara T , Katayama T , Arai H , Matsuura K , Nagata K , Maruo E
Ref : Jma j , 7 :292 , 2024
Abstract :
PubMedSearch : Suzuki_2024_Jma.j_7_292
PubMedID: 38721068

Title : Evaluating the Efficacy of Chronic Galantamine on Sustained Attention and Cholinergic Neurotransmission in A Pre-Clinical Model of Traumatic Brain Injury - Moschonas_2024_J.Neurotrauma__
Author(s) : Moschonas EH , Capeci HE , Annas EM , Domyslawski VB , Steber JA , Donald HM , Genkinger NR , Rennerfeldt PL , Bittner RA , Vozzella VJ , Cheng JP , Kline AE , Bondi CO
Ref : Journal of Neurotrauma , : , 2024
Abstract :
PubMedSearch : Moschonas_2024_J.Neurotrauma__
PubMedID: 38994598

Title : A Comprehensive Analysis on Galantamine Based Hybrids for the Management of Alzheimer's Disease - Singh_2024_Chem.Biol.Drug.Des_104_e70004
Author(s) : Singh YP , Prasad S , Kumar H
Ref : Chemical Biology Drug Des , 104 :e70004 , 2024
Abstract :
PubMedSearch : Singh_2024_Chem.Biol.Drug.Des_104_e70004
PubMedID: 39494477

Title : Functionalized Graphene Quantum Dots as an Eco-Friendly Fluorescent Probe for Galantamine Analysis: Greenness Evaluation With Application to Pharmacokinetics Monitoring - Alosaimi_2024_Luminescence_39_e70060
Author(s) : Alosaimi ME , Almalki AH , Abduljabbar MH , Alnemari RM , Alaqel SI , Serag A
Ref : Luminescence , 39 :e70060 , 2024
Abstract :
PubMedSearch : Alosaimi_2024_Luminescence_39_e70060
PubMedID: 39702891

Title : A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID beta and Reduce In Vitro Neurotoxicity - Kola_2023_Int.J.Mol.Sci_24_
Author(s) : Kola A , Lamponi S , Curro F , Valensin D
Ref : Int J Mol Sci , 24 : , 2023
Abstract :
PubMedSearch : Kola_2023_Int.J.Mol.Sci_24_
PubMedID: 36768823

Title : Static Binding and Dynamic Transporting-Based Design of Specific Ring-Chain-Ring Acetylcholinesterase Inhibitor: From Galantamine to Natural Product - Zhang_2023_Chemistry__e202203363
Author(s) : Zhang Z , Lv J , Wang Y , Yu H , Guo B , Zhai J , Wang C , Zhao Y , Fan F , Luo W
Ref : Chemistry , :e202203363 , 2023
Abstract :
PubMedSearch : Zhang_2023_Chemistry__e202203363
PubMedID: 36826395

Title : Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity - Alsikhan_2023_Brain.Sci_13_
Author(s) : Alsikhan RS , Aldubayan MA , Almami IS , Alhowail AH
Ref : Brain Sci , 13 : , 2023
Abstract :
PubMedSearch : Alsikhan_2023_Brain.Sci_13_
PubMedID: 37371449

Title : Therapeutic and medicinal effects of snowdrop (Galanthus spp.) in Alzheimer's disease: A review - Babashpour-Asl_2023_J.Educ.Health.Promot_12_128
Author(s) : Babashpour-Asl M , Kaboudi PS , Barez SR
Ref : J Educ Health Promot , 12 :128 , 2023
Abstract :
PubMedSearch : Babashpour-Asl_2023_J.Educ.Health.Promot_12_128
PubMedID: 37397105

Title : Galantamine improves glycemic control and diabetic nephropathy in Lepr(db\/db) mice - Meng_2023_Sci.Rep_13_15544
Author(s) : Meng Q , Ma J , Suo L , Pruekprasert N , Chakrapani P , Cooney RN
Ref : Sci Rep , 13 :15544 , 2023
Abstract :
PubMedSearch : Meng_2023_Sci.Rep_13_15544
PubMedID: 37731032

Title : A Cobalt-Containing Compound as a Stronger Inhibitor than Galantamine to Inhibit Acetylcholinesterase Activity: A New Drug Candidate for Alzheimer's Disease Treatment - Kalari_2022_J.Alzheimers.Dis__
Author(s) : Kalari M , Abbasi Z , Shasaltaneh MD , Khaleghian A , Moosavi-Nejad Z
Ref : J Alzheimers Dis , : , 2022
Abstract :
PubMedSearch : Kalari_2022_J.Alzheimers.Dis__
PubMedID: 35527546

Title : Chemical Survey of Three Species of the Genus Rauhia Traub (Amaryllidaceae) - Tallini_2022_Plants.(Basel)_11_
Author(s) : Tallini LR , Osorio EH , Berkov S , Torras-Claveria L , Rodriguez-Escobar ML , Viladomat F , Meerow AW , Bastida J
Ref : Plants (Basel) , 11 : , 2022
Abstract :
PubMedSearch : Tallini_2022_Plants.(Basel)_11_
PubMedID: 36559661

Title : The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial - Sangaleti_2021_Front.Immunol_12_613979
Author(s) : Sangaleti CT , Katayama KY , De Angelis K , Lemos de Moraes T , Araujo AA , Lopes HF , Camacho C , Bortolotto LA , Michelini LC , Irigoyen MC , Olofsson PS , Barnaby DP , Tracey KJ , Pavlov VA , Consolim Colombo FM
Ref : Front Immunol , 12 :613979 , 2021
Abstract :
PubMedSearch : Sangaleti_2021_Front.Immunol_12_613979
PubMedID: 33776997

Title : Dextran Sodium Sulphate-Induced Gastrointestinal Injury Further Aggravates the Impact of Galantamine on the Gastric Myoelectric Activity in Experimental Pigs - Bures_2021_Pharmaceuticals.(Basel)_14_
Author(s) : Bures J , Tacheci I , Kvetina J , Radochova V , Kohoutova D , Valis M , Rejchrt S , Knoblochova V , Karasova JZ
Ref : Pharmaceuticals (Basel) , 14 : , 2021
Abstract :
PubMedSearch : Bures_2021_Pharmaceuticals.(Basel)_14_
PubMedID: 34207410

Title : Loss of Basal Forebrain Cholinergic Neurons Following Adolescent Binge Ethanol Exposure: Recovery With the Cholinesterase Inhibitor Galantamine - Crews_2021_Front.Behav.Neurosci_15_652494
Author(s) : Crews FT , Fisher R , Deason C , Vetreno RP
Ref : Front Behavioral Neuroscience , 15 :652494 , 2021
Abstract :
PubMedSearch : Crews_2021_Front.Behav.Neurosci_15_652494
PubMedID: 33716687

Title : Oral Pretreatment with Galantamine Effectively Mitigates the Acute Toxicity of a Supralethal Dose of Soman in Cynomolgus Monkeys Posttreated with Conventional Antidotes - Lane_2020_J.Pharmacol.Exp.Ther_375_115
Author(s) : Lane M , Carter D , Pescrille JD , Aracava Y , Fawcett WP , Basinger GW , Pereira EFR , Albuquerque EX
Ref : Journal of Pharmacology & Experimental Therapeutics , 375 :115 , 2020
Abstract :
PubMedSearch : Lane_2020_J.Pharmacol.Exp.Ther_375_115
PubMedID: 32759369

Title : Gigantelline, gigantellinine and gigancrinine, cherylline- and crinine-type alkaloids isolated from Crinum jagus with anti-acetylcholinesterase activity - Ka_2020_Phytochemistry_175_112390
Author(s) : Ka S , Masi M , Merindol N , Di Lecce R , Plourde MB , Seck M , Gorecki M , Pescitelli G , Desgagne-Penix I , Evidente A
Ref : Phytochemistry , 175 :112390 , 2020
Abstract :
PubMedSearch : Ka_2020_Phytochemistry_175_112390
PubMedID: 32335411

Title : Galanthamine improves myocardial ischemia-reperfusion-induced cardiac dysfunction, endoplasmic reticulum stress-related apoptosis, and myocardial fibrosis by suppressing AMPK\/Nrf2 pathway in rats - Hou_2019_Ann.Transl.Med_7_634
Author(s) : Hou X , Fu M , Cheng B , Kang Y , Xie D
Ref : Ann Transl Med , 7 :634 , 2019
Abstract :
PubMedSearch : Hou_2019_Ann.Transl.Med_7_634
PubMedID: 31930035

Title : Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice - Sunena_2019_Curr.Drug.Deliv_16_51
Author(s) : Sunena , Singh SK , Mishra DN
Ref : Curr Drug Deliv , 16 :51 , 2019
Abstract :
PubMedSearch : Sunena_2019_Curr.Drug.Deliv_16_51
PubMedID: 30289074

Title : Double-Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use - Carroll_2019_Am.J.Addict_28_238
Author(s) : Carroll KM , DeVito EE , Yip SW , Nich C , Sofuoglu M
Ref : Am J Addict , 28 :238 , 2019
Abstract :
PubMedSearch : Carroll_2019_Am.J.Addict_28_238
PubMedID: 31165574

Title : Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome - Zhao_2018_J.Neurotrauma_35_362
Author(s) : Zhao J , Hylin MJ , Kobori N , Hood KN , Moore AN , Dash PK
Ref : Journal of Neurotrauma , 35 :362 , 2018
Abstract :
PubMedSearch : Zhao_2018_J.Neurotrauma_35_362
PubMedID: 29088998

Title : Neuroprotective Effects of Galantamine on Nerve Agent-Induced Neuroglial and Biochemical Changes - Golime_2018_Neurotox.Res_33_738
Author(s) : Golime R , Palit M , Acharya J , Dubey DK
Ref : Neurotox Res , 33 :738 , 2018
Abstract :
PubMedSearch : Golime_2018_Neurotox.Res_33_738
PubMedID: 28929435

Title : Cholinesterase-inhibitory effect and in silico analysis of alkaloids from bulbs of Hieronymiella species - Ortiz_2018_Phytomedicine_39_66
Author(s) : Ortiz JE , Garro A , Pigni NB , Aguero MB , Roitman G , Slanis A , Enriz RD , Feresin GE , Bastida J , Tapia A
Ref : Phytomedicine , 39 :66 , 2018
Abstract :
PubMedSearch : Ortiz_2018_Phytomedicine_39_66
PubMedID: 29433685

Title : Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study - Rocha_2018_J.Biomol.Struct.Dyn__1
Author(s) : Rocha REO , Lima LHF
Ref : J Biomol Struct Dyn , :1 , 2018
Abstract :
PubMedSearch : Rocha_2018_J.Biomol.Struct.Dyn__1
PubMedID: 29697300

Title : The Synthesis of Certain Derivatives and Analogues of (-)- and (+)-Galanthamine and an Assessment of their Capacities to Inhibit Acetylcholine Esterase - Buckler_2017_J.Org.Chem_82_7869
Author(s) : Buckler JN , Taher ES , Fraser NJ , Willis AC , Carr PD , Jackson CJ , Banwell MG
Ref : J Org Chem , 82 :7869 , 2017
Abstract :
PubMedSearch : Buckler_2017_J.Org.Chem_82_7869
PubMedID: 28671462

Title : Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid - Bloniecki_2017_J.Alzheimers.Dis_57_387
Author(s) : Bloniecki V , Aarsland D , Blennow K , Cummings J , Falahati F , Winblad B , Freund-Levi Y
Ref : J Alzheimers Dis , 57 :387 , 2017
Abstract :
PubMedSearch : Bloniecki_2017_J.Alzheimers.Dis_57_387
PubMedID: 28269767

Title : Advanced Structure-activity Relationships Applied to Mentha spicata L. Subsp. spicata Essential Oil Compounds as AChE and NMDA Ligands, in Comparison with Donepezil, Galantamine and Memantine - New Approach in Brain Disorders Pharmacology - Avram_2017_CNS.Neurol.Disord.Drug.Targets_16_800
Author(s) : Avram S , Mernea M , Bagci E , Hritcu L , Borcan LC , Mihailescu DF
Ref : CNS Neurol Disord Drug Targets , 16 :800 , 2017
Abstract :
PubMedSearch : Avram_2017_CNS.Neurol.Disord.Drug.Targets_16_800
PubMedID: 28088901

Title : Galanthamine, Plicamine, and Secoplicamine Alkaloids from Zephyranthes candida and Their Anti-acetylcholinesterase and Anti-inflammatory Activities - Zhan_2016_J.Nat.Prod_79_760
Author(s) : Zhan G , Zhou J , Liu R , Liu T , Guo G , Wang J , Xiang M , Xue Y , Luo Z , Zhang Y , Yao G
Ref : Journal of Natural Products , 79 :760 , 2016
Abstract :
PubMedSearch : Zhan_2016_J.Nat.Prod_79_760
PubMedID: 26913788

Title : Galanthamine decreases genotoxicity and cell death induced by beta-amyloid peptide in SH-SY5Y cell line - Castillo_2016_Neurotoxicol_57_291
Author(s) : Castillo WO , Aristizabal-Pachon AF , de Lima Montaldi AP , Sakamoto-Hojo ET , Takahashi CS
Ref : Neurotoxicology , 57 :291 , 2016
Abstract :
PubMedSearch : Castillo_2016_Neurotoxicol_57_291
PubMedID: 27793617

Title : Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina - Bezerra_2016_Molecules_21_
Author(s) : Bezerra da Silva C , Pott A , Elifio-Esposito S , Dalarmi L , Fialho do Nascimento K , Moura Burci L , de Oliveira M , de Fatima Gaspari Dias J , Maria Warumby Zanin S , Gomes Miguel O , Dallarmi Miguel M
Ref : Molecules , 21 : , 2016
Abstract :
PubMedSearch : Bezerra_2016_Molecules_21_
PubMedID: 26760993

Title : Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil - Hwang_2016_Psychiatry.Investig_13_341
Author(s) : Hwang TY , Ahn IS , Kim S , Kim DK
Ref : Psychiatry Investig , 13 :341 , 2016
Abstract :
PubMedSearch : Hwang_2016_Psychiatry.Investig_13_341
PubMedID: 27247602

Title : Subthreshold Concentrations of Melatonin and Galantamine Improves Pathological AD-Hallmarks in Hippocampal Organotypic Cultures - Buendia_2016_Mol.Neurobiol_53_3338
Author(s) : Buendia I , Parada E , Navarro E , Leon R , Negredo P , Egea J , Lopez MG
Ref : Molecular Neurobiology , 53 :3338 , 2016
Abstract :
PubMedSearch : Buendia_2016_Mol.Neurobiol_53_3338
PubMedID: 26081146

Title : Docking-based Design of Galantamine Derivatives with Dual-site Binding to Acetylcholinesterase - Stavrakov_2016_Mol.Inform_35_278
Author(s) : Stavrakov G , Philipova I , Zheleva D , Atanasova M , Konstantinov S , Doytchinova I
Ref : Mol Inform , 35 :278 , 2016
Abstract :
PubMedSearch : Stavrakov_2016_Mol.Inform_35_278
PubMedID: 27492242

Title : Galanthamine, an acetylcholine inhibitor, prevents prepulse inhibition deficits induced by adolescent social isolation or MK-801 treatment - Shao_2014_Brain.Res_1589_105
Author(s) : Shao S , Li M , Du W , Shao F , Wang W
Ref : Brain Research , 1589 :105 , 2014
Abstract :
PubMedSearch : Shao_2014_Brain.Res_1589_105
PubMedID: 25281804

Title : Galanthamine, an anti-cholinesterase drug, effects plant growth and development in Artemisia tridentata Nutt. via modulation of auxin and neurotransmitter signaling - Turi_2014_Plant.Signal.Behav_9_e28645
Author(s) : Turi CE , Axwik KE , Smith A , Jones AM , Saxena PK , Murch SJ
Ref : Plant Signal Behav , 9 :e28645 , 2014
Abstract :
PubMedSearch : Turi_2014_Plant.Signal.Behav_9_e28645
PubMedID: 24690897

Title : The prediction of response to Galantamine treatment in Patients with mild to moderate Alzheimer's Disease - Ohnishi_2014_Curr.Alzheimer.Res_11_110
Author(s) : Ohnishi T , Sakiyama Y , Okuri Y , Kimura Y , Sugiyama N , Saito T , Takahashi M , Kobayashi T
Ref : Curr Alzheimer Res , 11 :110 , 2014
Abstract :
PubMedSearch : Ohnishi_2014_Curr.Alzheimer.Res_11_110
PubMedID: 24156269

Title : Alkaloids from Habranthus tubispathus and H. jamesonii, two amaryllidaceae with acetyl- and butyrylcholinesterase inhibition activity - Cavallaro_2014_Nat.Prod.Commun_9_159
Author(s) : Cavallaro V , Alza NP , Murray MG , Murray AP
Ref : Nat Prod Commun , 9 :159 , 2014
Abstract :
PubMedSearch : Cavallaro_2014_Nat.Prod.Commun_9_159
PubMedID: 24689279

Title : Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity - Lopes_2013_Brain.Behav_3_67
Author(s) : Lopes JP , Tarozzo G , Reggiani A , Piomelli D , Cavalli A
Ref : Brain Behav , 3 :67 , 2013
Abstract :
PubMedSearch : Lopes_2013_Brain.Behav_3_67
PubMedID: 23532860

Title : Structures of human acetylcholinesterase in complex with pharmacologically important ligands - Cheung_2012_J.Med.Chem_55_10282
Author(s) : Cheung J , Rudolph MJ , Burshteyn F , Cassidy MS , Gary EN , Love J , Franklin MC , Height JJ
Ref : Journal of Medicinal Chemistry , 55 :10282 , 2012
Abstract :
PubMedSearch : Cheung_2012_J.Med.Chem_55_10282
PubMedID: 23035744
Gene_locus related to this paper: human-ACHE

Title : Wild Argentinian Amaryllidaceae, a New Renewable Source of the Acetylcholinesterase Inhibitor Galanthamine and Other Alkaloids - Ortiz_2012_Molecules_17_13473
Author(s) : Ortiz JE , Berkov S , Pigni NB , Theoduloz C , Roitman G , Tapia A , Bastida J , Feresin GE
Ref : Molecules , 17 :13473 , 2012
Abstract :
PubMedSearch : Ortiz_2012_Molecules_17_13473
PubMedID: 23149565

Title : GC-MS of amaryllidaceous galanthamine-type alkaloids - Berkov_2012_J.Mass.Spectrom_47_1065
Author(s) : Berkov S , Viladomat F , Codina C , Suarez S , Ravelo A , Bastida J
Ref : J Mass Spectrom , 47 :1065 , 2012
Abstract :
PubMedSearch : Berkov_2012_J.Mass.Spectrom_47_1065
PubMedID: 22899516

Title : Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats - Gibbs_2011_Horm.Behav_60_607
Author(s) : Gibbs RB , Chipman AM , Hammond R , Nelson D
Ref : Horm Behav , 60 :607 , 2011
Abstract :
PubMedSearch : Gibbs_2011_Horm.Behav_60_607
PubMedID: 21889940

Title : The dramatic effects of Galantamine in a patient with early-onset Alzheimer's disease - Dev_2010_Psychiatr.Danub_22_367
Author(s) : Dev H , Agius M , Zaman R
Ref : Psychiatr Danub , 22 :367 , 2010
Abstract :
PubMedSearch : Dev_2010_Psychiatr.Danub_22_367
PubMedID: 20562785

Title : Rapid TLC\/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extracts - Berkov_2008_Phytochem.Anal_19_411
Author(s) : Berkov S , Bastida J , Nikolova M , Viladomat F , Codina C
Ref : Phytochem Anal , 19 :411 , 2008
Abstract :
PubMedSearch : Berkov_2008_Phytochem.Anal_19_411
PubMedID: 18446766

Title : Galanthamine, a natural product for the treatment of Alzheimer's disease - Marco_2006_Recent.Pat.CNS.Drug.Discov_1_105
Author(s) : Marco L , do Carmo Carreiras M
Ref : Recent Pat CNS Drug Discov , 1 :105 , 2006
Abstract :
PubMedSearch : Marco_2006_Recent.Pat.CNS.Drug.Discov_1_105
PubMedID: 18221196

Title : Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis-lesioned and aged rats - Rispoli_2006_Pharmacol.Biochem.Behav_84_453
Author(s) : Rispoli V , Marra R , Costa N , Scipione L , Rotiroti D , De Vita D , Liberatore F , Carelli V
Ref : Pharmacol Biochem Behav , 84 :453 , 2006
Abstract :
PubMedSearch : Rispoli_2006_Pharmacol.Biochem.Behav_84_453
PubMedID: 16859739

Title : The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design - Greenblatt_2004_J.Am.Chem.Soc_126_15405
Author(s) : Greenblatt HM , Guillou C , Guenard D , Argaman A , Botti SA , Badet B , Thal C , Silman I , Sussman JL
Ref : Journal of the American Chemical Society , 126 :15405 , 2004
Abstract :
PubMedSearch : Greenblatt_2004_J.Am.Chem.Soc_126_15405
PubMedID: 15563167
Gene_locus related to this paper: torca-ACHE

Title : Poster (77) Galanthamine inhibits the aggregation of the amyloid-beta-peptide stimulated by acetylcholinesterase in vitro. -
Author(s) : Dinamarca MC , Campos EO , Hancke JL , Rakonczay Z , Inestrosa NC
Ref : In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects , (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina :361 , 2004
PubMedID:

Title : Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge - Heinrich_2004_J.Ethnopharmacol_92_147
Author(s) : Heinrich M , Lee Teoh H
Ref : J Ethnopharmacol , 92 :147 , 2004
Abstract :
PubMedSearch : Heinrich_2004_J.Ethnopharmacol_92_147
PubMedID: 15137996

Title : Galanthamine pattern in Narcissus confusus plants - Lopez_2003_Planta.Med_69_1166
Author(s) : Lopez S , Bastida J , Viladomat F , Codina C
Ref : Planta Med , 69 :1166 , 2003
Abstract :
PubMedSearch : Lopez_2003_Planta.Med_69_1166
PubMedID: 14750039

Title : Assessment of Health Economics in Alzheimer's Disease (AHEAD): Treatment with Galantamine in Sweden - Garfield_2002_Pharmacoeconomics_20_629
Author(s) : Garfield FB , Getsios D , Caro JJ , Wimo A , Winblad B
Ref : Pharmacoeconomics , 20 :629 , 2002
Abstract :
PubMedSearch : Garfield_2002_Pharmacoeconomics_20_629
PubMedID: 12141890

Title : [New theory! Galantamine and nicotinic-cholinergic transmission] -
Author(s) : Maelicke A , Weichel C
Ref : Pharm Unserer Zeit , 31 :390 , 2002
PubMedID: 12162069

Title : Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts - Lopez_2002_Life.Sci_71_2521
Author(s) : Lopez S , Bastida J , Viladomat F , Codina C
Ref : Life Sciences , 71 :2521 , 2002
Abstract :
PubMedSearch : Lopez_2002_Life.Sci_71_2521
PubMedID: 12270757

Title : Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs - Bartolucci_2001_Proteins_42_182
Author(s) : Bartolucci C , Perola E , Pilger C , Fels G , Lamba D
Ref : Proteins , 42 :182 , 2001
Abstract :
PubMedSearch : Bartolucci_2001_Proteins_42_182
PubMedID: 11119642
Gene_locus related to this paper: torca-ACHE

Title : Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning - Woodruff-Pak_2001_Proc.Natl.Acad.Sci.U.S.A_98_2089
Author(s) : Woodruff-Pak DS , Vogel RW , Wenk GL
Ref : Proceedings of the National Academy of Sciences of the United States of America , 98 :2089 , 2001
Abstract :
PubMedSearch : Woodruff-Pak_2001_Proc.Natl.Acad.Sci.U.S.A_98_2089
PubMedID: 11172080

Title : Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease - Coyle_2001_Biol.Psychiatry_49_289
Author(s) : Coyle J , Kershaw P
Ref : Biological Psychiatry , 49 :289 , 2001
Abstract :
PubMedSearch : Coyle_2001_Biol.Psychiatry_49_289
PubMedID: 11230880

Title : Galantamine: additional benefits to patients with Alzheimer's disease - Lilienfeld_2000_Dement.Geriatr.Cogn.Disord_11 Suppl 1_19
Author(s) : Lilienfeld S , Parys W
Ref : Dementia & Geriatric Cognitive Disorders , 11 Suppl 1 :19 , 2000
Abstract :
PubMedSearch : Lilienfeld_2000_Dement.Geriatr.Cogn.Disord_11 Suppl 1_19
PubMedID: 10971048

Title : Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group - Raskind_2000_Neurology_54_2261
Author(s) : Raskind MA , Peskind ER , Wessel T , Yuan W
Ref : Neurology , 54 :2261 , 2000
Abstract :
PubMedSearch : Raskind_2000_Neurology_54_2261
PubMedID: 10881250

Title : A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group - Tariot_2000_Neurology_54_2269
Author(s) : Tariot PN , Solomon PR , Morris JC , Kershaw P , Lilienfeld S , Ding C
Ref : Neurology , 54 :2269 , 2000
Abstract :
PubMedSearch : Tariot_2000_Neurology_54_2269
PubMedID: 10881251

Title : Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts - Guillou_2000_Bioorg.Med.Chem.Lett_10_637
Author(s) : Guillou C , Mary A , Renko DZ , Gras E , Thal C
Ref : Bioorganic & Medicinal Chemistry Lett , 10 :637 , 2000
Abstract :
PubMedSearch : Guillou_2000_Bioorg.Med.Chem.Lett_10_637
PubMedID: 10762042

Title : Capillary zone electrophoresis determination of galanthamine in biological fluids and pharmaceutical preparatives: experimental design and artificial neural network optimization - Pokorna_1999_Electrophoresis_20_1993
Author(s) : Pokorna L , Revilla A , Havel J , Patocka J
Ref : Electrophoresis , 20 :1993 , 1999
Abstract :
PubMedSearch : Pokorna_1999_Electrophoresis_20_1993
PubMedID: 10451107

Title : The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6 - Bachus_1999_Pharmacogenet_9_661
Author(s) : Bachus R , Bickel U , Thomsen T , Roots I , Kewitz H
Ref : Pharmacogenetics , 9 :661 , 1999
Abstract :
PubMedSearch : Bachus_1999_Pharmacogenet_9_661
PubMedID: 10634129

Title : Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution - Greenblatt_1999_FEBS.Lett_463_321
Author(s) : Greenblatt HM , Kryger G , Lewis T , Silman I , Sussman JL
Ref : FEBS Letters , 463 :321 , 1999
Abstract :
PubMedSearch : Greenblatt_1999_FEBS.Lett_463_321
PubMedID: 10606746
Gene_locus related to this paper: torca-ACHE

Title : Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington - Davis_1999_Geriatrics_54_42
Author(s) : Davis KL
Ref : Geriatrics , 54 :42 , 1999
Abstract :
PubMedSearch : Davis_1999_Geriatrics_54_42
PubMedID: 10024872

Title : Effect of the acetylcholinesterase inhibitor galanthamine on learning and memory in prolonged alcohol intake rat model of acetylcholine deficit - Iliev_1999_Methods.Find.Exp.Clin.Pharmacol_21_297
Author(s) : Iliev A , Traykov V , Prodanov D , Mantchev G , Yakimova K , Krushkov I , Boyadjieva N
Ref : Methods Find Exp Clin Pharmacol , 21 :297 , 1999
Abstract :
PubMedSearch : Iliev_1999_Methods.Find.Exp.Clin.Pharmacol_21_297
PubMedID: 10399139

Title : Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series - Mary_1998_Bioorg.Med.Chem_6_1835
Author(s) : Mary A , Renko DZ , Guillou C , Thal C
Ref : Bioorganic & Medicinal Chemistry , 6 :1835 , 1998
Abstract :
PubMedSearch : Mary_1998_Bioorg.Med.Chem_6_1835
PubMedID: 9839013

Title : Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications - Giacobini_1998_Neurochem.Int_32_413
Author(s) : Giacobini E
Ref : Neurochem Int , 32 :413 , 1998
Abstract :
PubMedSearch : Giacobini_1998_Neurochem.Int_32_413
PubMedID: 9676739

Title : Evaluation of four Narcissus cultivars as potential sources for galanthamine production [letter] - Moraes-Cerdeira_1997_Planta.Med_63_472
Author(s) : Moraes-Cerdeira RM , Burandt CL, Jr. , Bastos JK , Nanayakkara D , Mikell J , Thurn J , McChesney JD
Ref : Planta Med , 63 :472 , 1997
Abstract :
PubMedSearch : Moraes-Cerdeira_1997_Planta.Med_63_472
PubMedID: 9342954

Title : Pharmacological basis of drug therapy of Alzheimer's disease - Sharma_1997_Indian.J.Exp.Biol_35_1146
Author(s) : Sharma A , Parikh V , Singh M
Ref : Indian J Exp Biol , 35 :1146 , 1997
Abstract :
PubMedSearch : Sharma_1997_Indian.J.Exp.Biol_35_1146
PubMedID: 9567741

Title : [The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances]. [Russian] - Prozorovskii_1996_Eksp.Klin.Farmakol_59_64
Author(s) : Prozorovskii VB , Velikova VD , Pshenkina NN , Vasilenko ET
Ref : Eksperimentalnaia i Klinicheskaia Farmakologiia , 59 :64 , 1996
Abstract :
PubMedSearch : Prozorovskii_1996_Eksp.Klin.Farmakol_59_64
PubMedID: 8704639

Title : Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine - Bores_1996_J.Pharmacol.Exp.Ther_277_728
Author(s) : Bores GM , Huger FP , Petko W , Mutlib AE , Camacho F , Rush DK , Selk DE , Wolf V , Kosley RW, Jr. , Davis L , Vargas HM
Ref : Journal of Pharmacology & Experimental Therapeutics , 277 :728 , 1996
Abstract :
PubMedSearch : Bores_1996_J.Pharmacol.Exp.Ther_277_728
PubMedID: 8627552

Title : Galanthamine. [Review] [23 refs] - Fulton_1996_Drugs.Aging_9_60
Author(s) : Fulton B , Benfield P
Ref : Drugs & Aging , 9 :60 , 1996
Abstract :
PubMedSearch : Fulton_1996_Drugs.Aging_9_60
PubMedID: 8818586

Title : Effect of the cholinesterase-inhibiting substance galanthamine on evoked visual potentials in rats - Lewandowski_1995_Acta.Neurobiol.Experiment_55_141
Author(s) : Lewandowski MH , Zmuda L
Ref : Acta Neurobiologiae Experimentalis , 55 :141 , 1995
Abstract :
PubMedSearch : Lewandowski_1995_Acta.Neurobiol.Experiment_55_141
PubMedID: 7660864

Title : Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells - Storch_1995_Eur.J.Pharmacol_290_207
Author(s) : Storch A , Schrattenholz A , Cooper JC , Abdel Ghani EM , Gutbrod O , Weber KH , Reinhardt S , Lobron C , Hermsen B , Soskic V , Pereira EF , Albuquerque EX , Methfessel C , Maelicke A
Ref : European Journal of Pharmacology , 290 :207 , 1995
Abstract :
PubMedSearch : Storch_1995_Eur.J.Pharmacol_290_207
PubMedID: 7589215

Title : The pharmacology of galanthamine and its analogues - Harvey_1995_Pharmacol.Ther_68_113
Author(s) : Harvey AL
Ref : Pharmacol Ther , 68 :113 , 1995
Abstract :
PubMedSearch : Harvey_1995_Pharmacol.Ther_68_113
PubMedID: 8604434

Title : [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers]. [Russian] - Prozorovskii_1994_Eksp.Klin.Farmakol_57_13
Author(s) : Prozorovskii VB , Livanov GA , Velikova VD , Afanas'ev VV , Pavlova LV
Ref : Eksperimentalnaia i Klinicheskaia Farmakologiia , 57 :13 , 1994
Abstract :
PubMedSearch : Prozorovskii_1994_Eksp.Klin.Farmakol_57_13
PubMedID: 7696893

Title : Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine - Thomsen_1991_Eur.J.Clin.Chem.Clin.Biochem_29_487
Author(s) : Thomsen T , Kaden B , Fischer JP , Bickel U , Barz H , Gusztony G , Cervos-Navarro J , Kewitz H
Ref : European Journal of Clinical Chemistry & Clinical Biochemistry , 29 :487 , 1991
Abstract :
PubMedSearch : Thomsen_1991_Eur.J.Clin.Chem.Clin.Biochem_29_487
PubMedID: 1954303

Title : Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo - Thomsen_1990_Life.Sci_46_1553
Author(s) : Thomsen T , Kewitz H
Ref : Life Sciences , 46 :1553 , 1990
Abstract :
PubMedSearch : Thomsen_1990_Life.Sci_46_1553
PubMedID: 2355800

Title : [Catalytic properties of cholinesterases immobilized in a gelatin membrane] - Kuznetsova_1990_Ukr.Biokhim.Zh_62_42
Author(s) : Kuznetsova LP , Kugusheva LI , Nikol'skaia EB
Ref : Ukr Biokhim Zh , 62 :42 , 1990
Abstract :
PubMedSearch : Kuznetsova_1990_Ukr.Biokhim.Zh_62_42
PubMedID: 2087792

Title : Pharmacokinetics of galanthamine (a long-acting anticholinesterase drug) in anaesthetized patients - Westra_1986_Br.J.Anaesth_58_1303
Author(s) : Westra P , van Thiel MJ , Vermeer GA , Soeterbroek AM , Scaf AH , Claessens HA
Ref : British Journal of Anaesthesia , 58 :1303 , 1986
Abstract :
PubMedSearch : Westra_1986_Br.J.Anaesth_58_1303
PubMedID: 3778794

Title : [Miniature currents of the endplates of the muscle fibers of the diaphragm of the rat after inhibition of acetylcholinesterase with galanthamine] - Krivoi_1985_Neirofiziologiia_17_607
Author(s) : Krivoi II , Kuleshov VI , Matiushkin DP , Sanotskii VI , Sei TP
Ref : Neirofiziologiia , 17 :607 , 1985
Abstract :
PubMedSearch : Krivoi_1985_Neirofiziologiia_17_607
PubMedID: 2999623

Title : Homer's moly identified as Galanthus nivalis L.: physiologic antidote to stramonium poisoning - Plaitakis_1983_Clin.Neuropharmacol_6_1
Author(s) : Plaitakis A , Duvoisin RC
Ref : Clinical Neuropharmacology , 6 :1 , 1983
Abstract :
PubMedSearch : Plaitakis_1983_Clin.Neuropharmacol_6_1
PubMedID: 6342763

Title : Reversal of central anticholinergic syndrome by galanthamine - Baraka_1977_Jama_238_2293
Author(s) : Baraka A , Harik S
Ref : Jama , 238 :2293 , 1977
Abstract :
PubMedSearch : Baraka_1977_Jama_238_2293
PubMedID: 578850

Title : [Characteristics of galanthamine as a reversible inhibitor of cholinesterase] -
Author(s) : Vasilenko ET , Tonkopii VD
Ref : Biokhimiia , 39 :701 , 1974
PubMedID: 4441566

Title : Studies on the synthesis of heterocyclic compounds. CCCXV. Modified total synthesis of (plus or minus)-galanthamine through phenol oxidation -
Author(s) : Kametani T , Yamaki K , Yagi H , Fukumoto K
Ref : J Chem Soc Perkin 1 , 18 :2602 , 1969
PubMedID: 5391300

Title : Galanthamine chemistry. VII. Synthesis of analogues of galanthamine -
Author(s) : Uyeo S , Shirai H , Koshiro A , Yashiro T , Kagei K
Ref : Chem Pharm Bull (Tokyo) , 14 :1033 , 1966
PubMedID: 5976510

Title : [Influence exerted by galanthamine on the acetylcholinesterase activity of various regions of the brain] -
Author(s) : Nesterenko LN
Ref : Farmakologiia i Toksikologiia , 28 :413 , 1965
PubMedID: 5868403

Title : On the pharmacology of the new alkaloid galantamine -
Author(s) : Mashkovsky MD , Kruglikova-Lvova RP
Ref : Farmakologia Toxicologia (Moskow) , 14 :27 , 1951
PubMedID: